NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Pharmaceutical funding

By Irish Pharmacist - 03rd Feb 2020

Pharma pays over €8 million to hospitals, clinical societies

Healthcare organisations, including hospitals, were provided with over €8 million in funding by the pharmaceutical industry in 2018, according to figures.

The payments are listed on the pharmaceutical company pages within the transfer of value (ToV) register, which was established by the Irish Pharmaceutical Healthcare Association (IPHA).

The organisations include public hospitals, clinical societies, membership colleges and faculties, and hospital foundations. 

Higher-end payments to hospitals across the 44 company pages on the ToV register included €74,090 from Gilead and €63,229 from Janssen to the Mater Misericordiae University Hospital (MMUH), Dublin; €93,314 from Sanofi to the Tallaght University Hospital (TUH) cardiology department and €64,000 to TUH from Takeda; and €58,741 from Daiichi Sankyo and €85,686 from Novartis to Beaumont Hospital, Dublin.

A TUH spokesperson said: “With regard to the sums that you referenced, TUH received €93,314 from Sanofi into the TUH bank account. This project was supported by the hospital and the cardiology department, led by Prof Vincent Maher. The funding was to support the establishment of the Familial Hypercholesterolaemia (FH) National Network. All of the funds were used to support medical hours and nursing hours to carry out the research.  

“The €64,000 from Takeda was received by a research account with an address at TUH. TUH is named as the healthcare organisation with an address at TUH. The hospital only has governance over funds which are transferred into the hospital’s bank account so cannot comment.”

A spokesperson for MMUH said the cited payments “are disclosure of payments made to individuals for research and development, donations and grants (including medical education and unrestricted educational grants), consultancy fees, registration fees or travel costs to attend medical conferences.  These payments may have been made to an individual, or a service, within the Mater Misericordiae University Hospital.”

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist June 2024

Irish Pharmacist June 2024. Volume 25 | Issue 6 | June 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT